RC
Rajendrakumar Chhotalal Mehta
About Rajendrakumar Chhotalal Mehta
Data last updated:
Rajendrakumar Chhotalal Mehta has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Engram Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Engram Healthcare Private Limited at ₹2.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Engram Healthcare Private Limited U85100PN2013PTC146509 | Director | 06 Mar 2013 | 2013 | ₹2.41 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendrakumar Chhotalal Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendrakumar Chhotalal Mehta
Rajendrakumar Chhotalal Mehta has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Engram Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Engram Healthcare Private Limited at ₹2.41 Cr (FY 2025).
Rajendrakumar Chhotalal Mehta is associated with 1 company as Director, including Engram Healthcare Private Limited (₹2.41 Cr).
Rajendrakumar Chhotalal Mehta has expertise in Healthcare.
Rajendrakumar Chhotalal Mehta has 13 years in corporate governance.
By reported revenue, the largest current company of Rajendrakumar Chhotalal Mehta is Engram Healthcare Private Limited, with revenue of ₹2.41 Cr (FY 2025).
Rajendrakumar Chhotalal Mehta currently holds positions at 1 company: Engram Healthcare Private Limited (₹2.41 Cr).